细胞死亡在肿瘤中的研究进展
Advancements in the Research of Cell Death in Tumors
DOI: 10.12677/acm.2024.1471987, PDF,   
作者: 赖鑫燚, 刘继先*：北京大学深圳医院胸外科，广东 深圳
关键词: 细胞死亡；肿瘤；综述；Cell Death； Tumors； Review
摘要: 细胞死亡机制在肿瘤的发生、发展和治疗中扮演着关键角色。本文综述了细胞死亡的不同类型及其在肿瘤发病中的机制，特别关注了坏死性凋亡，细胞焦亡、铁死亡、铜死亡和双硫死亡的关键调控机制。并尝试对如何针对这些细胞死亡方式进行治疗开发做出讨论以期为癌症患者开发基于细胞死亡的新药提供思路。
Abstract: Cell death mechanisms play crucial roles in the occurrence, development, and treatment of tumors. This article reviews different types of cell death and their mechanisms in tumorigenesis, with a particular focus on necroptosis, ferroptosis, pyroptosis, and apoptosis, highlighting key regulatory mechanisms. It also attempts to discuss how to develop treatments targeting these cell death pathways, aiming to provide insights for the development of new drugs based on cell death for cancer patients.
文章引用：赖鑫燚, 刘继先. 细胞死亡在肿瘤中的研究进展[J]. 临床医学进展, 2024, 14(7): 96-101. https://doi.org/10.12677/acm.2024.1471987

参考文献

[1] Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. [Google Scholar] [CrossRef] [PubMed]
[2] Causeret, F., Sumia, I. and Pierani, A. (2015) Kremen1 and Dickkopf1 Control Cell Survival in a Wnt-Independent Manner. Cell Death & Differentiation, 23, 323-332. [Google Scholar] [CrossRef] [PubMed]
[3] Gottesman, M.M., Lavi, O., Hall, M.D. and Gillet, J. (2016) Toward a Better Understanding of the Complexity of Cancer Drug Resistance. Annual Review of Pharmacology and Toxicology, 56, 85-102. [Google Scholar] [CrossRef] [PubMed]
[4] Bäck, M., Yurdagul, A., Tabas, I., Öörni, K. and Kovanen, P.T. (2019) Inflammation and Its Resolution in Atherosclerosis: Mediators and Therapeutic Opportunities. Nature Reviews Cardiology, 16, 389-406. [Google Scholar] [CrossRef] [PubMed]
[5] Kist, M. and Vucic, D. (2021) Cell Death Pathways: Intricate Connections and Disease Implications. The EMBO Journal, 40, e106700. [Google Scholar] [CrossRef] [PubMed]
[6] Liu, Y., Bhattarai, P., Dai, Z. and Chen, X. (2019) Photothermal Therapy and Photoacoustic Imaging via Nanotheranostics in Fighting Cancer. Chemical Society Reviews, 48, 2053-2108. [Google Scholar] [CrossRef] [PubMed]
[7] Galluzzi, L., Vitale, I., Aaronson, S.A., Abrams, J.M., Adam, D., Agostinis, P., et al. (2018) Molecular Mechanisms of Cell Death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death & Differentiation, 25, 486-541. [Google Scholar] [CrossRef] [PubMed]
[8] Tang, D., Kang, R., Berghe, T.V., Vandenabeele, P. and Kroemer, G. (2019) The Molecular Machinery of Regulated Cell Death. Cell Research, 29, 347-364. [Google Scholar] [CrossRef] [PubMed]
[9] Shan, B., Pan, H., Najafov, A. and Yuan, J. (2018) Necroptosis in Development and Diseases. Genes & Development, 32, 327-340. [Google Scholar] [CrossRef] [PubMed]
[10] Dhuriya, Y.K. and Sharma, D. (2018) Necroptosis: A Regulated Inflammatory Mode of Cell Death. Journal of Neuroinflammation, 15, Article No. 199. [Google Scholar] [CrossRef] [PubMed]
[11] Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., et al. (2005) Chemical Inhibitor of Nonapoptotic Cell Death with Therapeutic Potential for Ischemic Brain Injury. Nature Chemical Biology, 1, 112-119. [Google Scholar] [CrossRef] [PubMed]
[12] Degterev, A., Hitomi, J., Germscheid, M., Chen, I.L., Korkina, O., Teng, X., et al. (2008) Identification of RIP1 Kinase as a Specific Cellular Target of Necrostatins. Nature Chemical Biology, 4, 313-321. [Google Scholar] [CrossRef] [PubMed]
[13] Yuan, J., Amin, P. and Ofengeim, D. (2018) Necroptosis and RIPK1-Mediated Neuroinflammation in CNS Diseases. Nature Reviews Neuroscience, 20, 19-33. [Google Scholar] [CrossRef] [PubMed]
[14] Luedde, M., Lutz, M., Carter, N., Sosna, J., Jacoby, C., Vucur, M., et al. (2014) RIP3, a Kinase Promoting Necroptotic Cell Death, Mediates Adverse Remodelling after Myocardial Infarction. Cardiovascular Research, 103, 206-216. [Google Scholar] [CrossRef] [PubMed]
[15] Oerlemans, M.I.F.J., Liu, J., Arslan, F., Ouden, K., Middelaar, B.J., Doevendans, P.A., et al. (2012) Inhibition of RIP1-Dependent Necrosis Prevents Adverse Cardiac Remodeling after Myocardial Ischemia-Reperfusion in vivo. Basic Research in Cardiology, 107, 270. [Google Scholar] [CrossRef] [PubMed]
[16] Kung, J.E. and Jura, N. (2019) Prospects for Pharmacological Targeting of Pseudokinases. Nature Reviews Drug Discovery, 18, 501-526. [Google Scholar] [CrossRef] [PubMed]
[17] Kwok, A.J., Mentzer, A. and Knight, J.C. (2020) Host Genetics and Infectious Disease: New Tools, Insights and Translational Opportunities. Nature Reviews Genetics, 22, 137-153. [Google Scholar] [CrossRef] [PubMed]
[18] Harris, P.A., King, B.W., Bandyopadhyay, D., Berger, S.B., Campobasso, N., Capriotti, C.A., et al. (2016) Dna-Encoded Library Screening Identifies Benzo[b][1,4]Oxazepin-4-Ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors. Journal of Medicinal Chemistry, 59, 2163-2178. [Google Scholar] [CrossRef] [PubMed]
[19] Harris, P.A., Berger, S.B., Jeong, J.U., Nagilla, R., Bandyopadhyay, D., Campobasso, N., et al. (2017) Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases. Journal of Medicinal Chemistry, 60, 1247-1261. [Google Scholar] [CrossRef] [PubMed]
[20] Frank, D. and Vince, J.E. (2018) Pyroptosis versus Necroptosis: Similarities, Differences, and Crosstalk. Cell Death & Differentiation, 26, 99-114. [Google Scholar] [CrossRef] [PubMed]
[21] Kayagaki, N., Warming, S., Lamkanfi, M., Walle, L.V., Louie, S., Dong, J., et al. (2011) Non-Canonical Inflammasome Activation Targets Caspase-11. Nature, 479, 117-121. [Google Scholar] [CrossRef] [PubMed]
[22] Martinon, F., Burns, K. and Tschopp, J. (2002) The Inflammasome: A Molecular Platform Triggering Activation of Inflammatory Caspases and Processing of proIL-β. Molecular Cell, 10, 417-426. [Google Scholar] [CrossRef] [PubMed]
[23] Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C. and Chen, X. (2021) Pyroptosis: Mechanisms and Diseases. Signal Transduction and Targeted Therapy, 6, Article No. 128. [Google Scholar] [CrossRef] [PubMed]
[24] Fearnhead, H.O., Vandenabeele, P. and Vanden Berghe, T. (2017) How Do We Fit Ferroptosis in the Family of Regulated Cell Death? Cell Death & Differentiation, 24, 1991-1998. [Google Scholar] [CrossRef] [PubMed]
[25] Jiang, X., Stockwell, B.R. and Conrad, M. (2021) Ferroptosis: Mechanisms, Biology and Role in Disease. Nature Reviews Molecular Cell Biology, 22, 266-282. [Google Scholar] [CrossRef] [PubMed]
[26] Conrad, M., Lorenz, S.M. and Proneth, B. (2021) Targeting Ferroptosis: New Hope for As-yet-Incurable Diseases. Trends in Molecular Medicine, 27, 113-122. [Google Scholar] [CrossRef] [PubMed]
[27] Lei, G., Zhuang, L. and Gan, B. (2022) Targeting Ferroptosis as a Vulnerability in Cancer. Nature Reviews Cancer, 22, 381-396. [Google Scholar] [CrossRef] [PubMed]
[28] Zhang, Y., Tan, H., Daniels, J.D., Zandkarimi, F., Liu, H., Brown, L.M., et al. (2019) Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model. Cell Chemical Biology, 26, 623-633. [Google Scholar] [CrossRef] [PubMed]
[29] Tsvetkov, P., Coy, S., Petrova, B., Dreishpoon, M., Verma, A., Abdusamad, M., et al. (2022) Copper Induces Cell Death by Targeting Lipoylated TCA Cycle Proteins. Science, 375, 1254-1261. [Google Scholar] [CrossRef] [PubMed]
[30] Lichtmannegger, J., Leitzinger, C., Wimmer, R., Schmitt, S., Schulz, S., Kabiri, Y., et al. (2016) Methanobactin Reverses Acute Liver Failure in a Rat Model of Wilson Disease. Journal of Clinical Investigation, 126, 2721-2735. [Google Scholar] [CrossRef] [PubMed]
[31] Liu, X., Nie, L., Zhang, Y., Yan, Y., Wang, C., Colic, M., et al. (2023) Actin Cytoskeleton Vulnerability to Disulfide Stress Mediates Disulfidptosis. Nature Cell Biology, 25, 404-414. [Google Scholar] [CrossRef] [PubMed]
[32] Liu, X., Zhuang, L. and Gan, B. (2024) Disulfidptosis: Disulfide Stress-Induced Cell Death. Trends in Cell Biology, 34, 327-337. [Google Scholar] [CrossRef] [PubMed]

为你推荐